Immediate Impact
1 from Science/Nature 53 standout
Citing Papers
An Update on the Nitrogen Heterocycle Compositions and Properties of U.S. FDA-Approved Pharmaceuticals (2013–2023)
2024 Standout
Targeted protein degradation: advances in drug discovery and clinical practice
2024 Standout
Works of Xiang Lu being referenced
Novel 11β-substituted estradiol conjugates: Transition from ERα agonizts to effective PROTAC degraders
2022
Synthesis, biological evaluation, and molecular docking studies of N,1,3-triphenyl-1H-pyrazole-4-carboxamide derivatives as anticancer agents
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Xiang Lu | 145 | 141 | 26 | 41 | 27 | 300 | |
| Seyed–Omar Zaraei | 191 | 202 | 13 | 67 | 36 | 366 | |
| Prashi Jain | 167 | 128 | 25 | 46 | 22 | 322 | |
| Jesús Vázquez | 264 | 97 | 17 | 65 | 12 | 361 | |
| Jianxin Yu | 178 | 73 | 34 | 52 | 19 | 363 | |
| Jinlian Wei | 155 | 114 | 10 | 46 | 26 | 324 | |
| Anna Gryboś | 145 | 115 | 7 | 32 | 26 | 322 | |
| Tadashi Terasaka | 217 | 75 | 17 | 34 | 20 | 343 | |
| Hassan Aryapour | 131 | 175 | 12 | 23 | 26 | 371 | |
| Peter H. Crackett | 91 | 181 | 30 | 40 | 18 | 293 | |
| Chiranjeev Sharma | 187 | 126 | 12 | 49 | 23 | 366 |
All Works
Login with ORCID to disown or claim papers
Loading papers...